BIO-TECHNE Corp
TECH· Nasdaq
Filed Aug 27, 2018 · 10-K · 58 days after period end · 0001437749-18-016190
| Metric | Q4 2018 | Q4 2017 | Q4 2016 | Q4 2015dderived from reported figures |
|---|---|---|---|---|
| Revenue | $180.25M | $156.58M | $134.76M | $117.66M |
| Net Income | $41.70M | $27.61M | $25.63M | $26.33M |
| EPS Diluted | $1.07 | $0.74 | $0.69 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
ended Jun 30, 2018 · filed Aug 27, 2018 · 58 d after period end